Evidence map›Paper›PMID 38352024›Full record

ArticlePain reports2024

A digital health intervention to support patients with chronic pain during prescription opioid tapering: a pilot randomised controlled trial.

Ali Gholamrezaei, Michael R Magee, Amy G McNeilage, Leah Dwyer, Alison Sim, Manuela L Ferreira, Beth D Darnall, Timothy Brake, Arun Aggarwal, Meredith Craigie and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pain reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Ali GholamrezaeiSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0001-8674-450X
Michael R MageeSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Amy G McNeilageSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Leah DwyerConsumer Advisory Group, Painaustralia, Deakin, Victoria, Australia.
Alison SimSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Manuela L FerreiraSydney Musculoskeletal Health, Kolling Institute, School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Beth D DarnallDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA.
Timothy BrakePain Management Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Arun AggarwalPain Management Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Meredith CraigiePain Management Unit, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, South Australia, Australia.
Irina HollingtonPain Management Unit, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, South Australia, Australia.
Paul GlareSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Claire E Ashton-JamesSydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0001-5547-4295
The University of Sydney · AUApple (Israel) · IL

Funding

Research and Mentoring in Innovative Patient Oriented Pain and Opioid ScienceK24DA053564 · NIDA · STANFORD UNIVERSITY · PI Beth Denise Darnall · 2021 to 2026
$1.0M
NIDA NIH HHS K24 DA053564
6 · The paper itself

Abstract

Introduction: Recent changes in opioid prescribing guidelines have led to an increasing number of patients with chronic pain being recommended to taper. However, opioid tapering can be challenging, and many patients require support. Objectives: We evaluated the feasibility, acceptability, and potential efficacy of a codesigned digital health intervention to support patients with chronic pain during voluntary prescription opioid tapering. Methods: In a pilot randomised controlled trial, participants received a psychoeducational video and 28 days of text messages (2 SMS/day) in addition to their usual care (intervention) or usual care alone (control). The feasibility, acceptability, and potential efficacy of the intervention were evaluated. The primary outcome was opioid tapering self-efficacy. Secondary outcomes were pain intensity and interference, anxiety and depression symptom severity, pain catastrophising, and pain self-efficacy. Results: Of 28 randomised participants, 26 completed the study (13 per group). Text message delivery was high (99.2%), but fidelity of video delivery was low (57.1%). Most participants rated the messages as useful, supportive, encouraging, and engaging; 78.5% would recommend the intervention to others; and 64.2% desired a longer intervention period. Tapering self-efficacy (Cohen Conclusion: First evidence supports the feasibility, acceptability, and potentially efficacy of a psychoeducational video and SMS text messaging intervention to support patients with chronic pain during voluntary prescription opioid tapering. Definitive trials with longer intervention duration are warranted.

Indexed as

Digital healthmHealthMobile healthOpioidPainTapering

Identifiers

PMID38352024
PMCPMC10863948
OpenAlexW4391754397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.